LysSYL-Loaded pH-Switchable Self-Assembling Peptide Hydrogels Promote Methicillin-Resistant Staphylococcus Aureus

He Liu1, Xuemei Wei2, Huagang Peng1

  • 1Department of Microbiology, College of Basic Medical Sciences, Army Medical University, Key Laboratory of Microbial Engineering under the Educational Committee in Chongqing, Chongqing, 400038, China.

Insights

A novel peptide hydrogel, L5@LysSYL, effectively combats methicillin-resistant Staphylococcus aureus (MRSA) wound infections. This pH-sensitive dressing promotes wound healing by releasing an endolysin and offers a promising solution for challenging infections.

Area of Science:

  • Biotechnology
  • Materials Science
  • Infectious Diseases

Background:

  • Staphylococcus aureus (S. aureus), particularly MRSA, causes difficult-to-treat wound infections.
  • Acidic conditions (pH 4.5-6.5) in infected wounds limit the efficacy of antimicrobial agents like endolysins.
  • Endolysins, such as LysSYL, show antistaphylococcal activity but suffer from instability and poor bioavailability in acidic environments.

Purpose of the Study:

  • To develop a pH-sensitive drug delivery system for endolysin LysSYL to treat S. aureus wound infections.
  • To create a self-assembling peptide hydrogel (L5) that enhances LysSYL stability and bioavailability.
  • To evaluate the antimicrobial efficacy and wound healing potential of the L5@LysSYL hydrogel in a preclinical model.

Main Methods:

  • Design and screening of self-assembling peptides, identifying L5 for its gelation and bioavailability.
  • Loading LysSYL into the L5 peptide to form L5@LysSYL hydrogels.
  • Assessment of L5@LysSYL hydrogel properties, including pH-switchable antimicrobial activity, stability, and drug release kinetics.
  • Evaluation of L5@LysSYL in a mouse model of MRSA-infected wounds, including efficacy, safety, and wound healing promotion.

Main Results:

  • Peptide L5 formed biocompatible hydrogels and exhibited pH-switchable antimicrobial activity.
  • L5@LysSYL hydrogels enhanced LysSYL's thermal stability and enabled slow release.
  • L5@LysSYL effectively eliminated S. aureus by disrupting bacterial membranes and inhibiting cell separation.
  • In vivo studies demonstrated that L5@LysSYL promoted MRSA wound healing, reduced cytokine levels, and increased pro-angiogenic factors.

Conclusions:

  • Self-assembling L5@LysSYL hydrogels provide an effective strategy for managing S. aureus wound infections.
  • The pH-sensitive nature and enhanced stability of L5@LysSYL make it a promising candidate for advanced wound dressings.
  • L5@LysSYL demonstrates significant potential for promoting wound healing and combating MRSA infections.